THC vs EHC
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
THC · Tenet Healthcare$283.33 ▼ 1.09%
EHC · Encompass Health$137.54 ▼ 2.64%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- THC +45.5%
- EHC +20.1%
Head to head
| Metric | THC | EHC |
|---|---|---|
| Price | $283.33 | $137.54 |
| Change today | ▼ 1.09% | ▼ 2.64% |
| Market cap | $22.55B | $13.50B |
| Return, 3 months | +9.0% | +9.3% |
| Return, year to date | +42.6% | +30.3% |
| Return, 1 year | +38.0% | +20.0% |
| P/E (TTM) | 8.3 | 21.5 |
| P/B | 4.1 | 5.0 |
| P/E percentile vs own 5y | 54th | 43rd |
| Dividend yield | – | 0.57% |
| Revenue growth (YoY, latest qtr) | +14.6% | +9.6% |
| Net profit growth (YoY) | +100.2% | +12.2% |
| Gross margin | 82.8% | 95.8% |
| Operating margin | 19.5% | 18.0% |
| Net margin | 9.9% | 10.0% |
| Return on equity | 53.3% | 25.4% |
| Analyst target vs. price | +1.8% | +6.7% |
| Analyst buy share | 88% | 100% |
| RSI (14) | 60 | 64 |
| 30-day volatility | 34.3% | 38.6% |
| Max drawdown, 1 year | -34.1% | -26.1% |
| Trend read | Strong uptrend | Strong uptrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- THC is the largest of the group by market value.
- THC has returned the most over the past year.
- THC carries the lowest trailing P/E.
- THC is growing revenue fastest.
- EHC keeps the most profit per dollar of sales.
- THC has been the calmest stock over the last 30 days.